Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 28 Oct 2026 07:04 CET |
ONCOINVENT ASA | Oncoinvent presents 3Q company update in live webcast | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Oct 2026 07:02 CET |
ONCOINVENT ASA | Oncoinvent ASA: Grant of share options to new Chief Medical Officer | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 28 Oct 2026 07:00 CET |
ONCOINVENT ASA | Oncoinvent appoints Dr Zuzana Jiráková Trnková as Chief Medical Officer to lead Phase 3 preparations for Radspherin[®] | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Oct 2026 07:00 CEST |
ONCOINVENT ASA | Invitation to business update - Wednesday 28 October 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Oct 2026 09:39 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Cancellation of subsequent repair offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Oct 2026 09:25 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 30 Sep 2026 16:25 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Mandatory notification of trade - Return of lent shares following Private Placement | 20103010 Biotechnology | Major shareholding notifications |
| 30 Sep 2026 10:39 CEST |
ONCOINVENT ASA | Oncoinvent ASA - New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 30 Sep 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent to present three abstracts at EANM and ESMO 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 23 Sep 2026 10:26 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 Sep 2026 10:14 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 23 Sep 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Ex. date | 20103010 Biotechnology | Ex Date |
| 23 Sep 2026 01:05 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Mandatory notification of trade - Allocation and share lending in Private Placement | 20103010 Biotechnology | Major shareholding notifications |
| 23 Sep 2026 00:45 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 Sep 2026 00:16 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Key information relating to subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Sep 2026 23:52 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Successful Private Placement and Retail Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Sep 2026 16:35 CEST |
ONCOINVENT ASA | Oncoinvent ASA - Contemplated private placement and retail offering | 20103010 Biotechnology | Inside information |
| 27 Aug 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent presents first half 2026 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 17 Aug 2026 07:00 CEST |
ONCOINVENT ASA | Invitation to First-Half 2026 webcast - Thursday 27 August 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Aug 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Jun 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin[®] | 20103010 Biotechnology | Non-regulatory press releases |
| 20 May 2026 20:55 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Grant of share options to member of the Board following AGM | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 20 May 2026 11:15 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Minutes from Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 May 2026 10:26 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Share capital decrease completed | 20103010 Biotechnology | Total number of voting rights and capital |
| 29 Apr 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent presents corporate update in live webcast | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Apr 2026 12:48 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2026 07:00 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Invitation to business update Wednesday 29 April 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Apr 2026 16:31 CEST |
ONCOINVENT ASA | Oncoinvent ASA: Annual Report for 2025 | 20103010 Biotechnology | Annual financial and audit Reports |
| 19 Mar 2026 07:00 CET |
ONCOINVENT ASA | Oncoinvent secures new patent expanding protection for Radspherin[®] | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Mar 2026 22:34 CET |
ONCOINVENT ASA | Oncoinvent ASA: Grant of share options to the CEO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 26 Feb 2026 07:00 CET |
ONCOINVENT ASA | Oncoinvent ASA: Second half 2025 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 17 Feb 2026 07:00 CET |
ONCOINVENT ASA | Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin[®] at ESGO 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Feb 2026 10:28 CET |
ONCOINVENT ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Feb 2026 10:28 CET |
ONCOINVENT ASA | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 29 Jan 2026 07:00 CET |
ONCOINVENT ASA | Four additional sites open for recruitment in Oncoinvent's Phase 2 trial | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Jan 2026 10:47 CET |
ONCOINVENT ASA | Oncoinvent ASA: Registration of reverse share split | 20103010 Biotechnology | Total number of voting rights and capital |
| 19 Jan 2026 07:00 CET |
ONCOINVENT ASA | Oncoinvent ASA: Ex. reverse share split and change of ISIN today | 20103010 Biotechnology | Ex Date |
| 15 Jan 2026 10:12 CET |
ONCOINVENT ASA | Oncoinvent ASA - New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 14 Jan 2026 15:49 CET |
ONCOINVENT ASA | Oncoinvent ASA: Key information relating to the reverse share split and change of ISIN | 20103010 Biotechnology | Total number of voting rights and capital |
| 13 Jan 2026 08:13 CET |
ONCOINVENT ASA | Oncoinvent ASA: Grant of share options to new CFO | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 08 Jan 2026 13:42 CET |
ONCOINVENT ASA | Oncoinvent ASA: Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Dec 2025 18:10 CET |
ONCOINVENT ASA | Oncoinvent ASA: Grant of share options - mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 18 Dec 2025 19:02 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notice of Extraordinary General Meeting | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 10 Dec 2025 18:15 CET |
ONCOINVENT ASA | Oncoinvent ASA: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 08 Dec 2025 10:49 CET |
ONCOINVENT ASA | Flaggemelding – Hadean Ventures AS / HVentures AB / Hadean Growth Fund I AS1 – Oncoinvent AS (ONCIN) | 20103010 Biotechnology | Flagging |
| 08 Dec 2025 07:00 CET |
ONCOINVENT ASA | Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Dec 2025 06:55 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notification of trade - primary insider/close associate | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 05 Dec 2025 14:01 CET |
ONCOINVENT ASA | NOTIFICATION OF MAJOR HOLDINGS | 20103010 Biotechnology | Major shareholding notifications |
| 05 Dec 2025 13:13 CET |
ONCOINVENT ASA | Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Dec 2025 13:05 CET |
ONCOINVENT ASA | Oncoinvent ASA: Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |